The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Pravat 40mg Tablets



Apotex Europe B.V.PA1513/008/003

Main Information

Trade NamePravat 40mg Tablets
Active SubstancesPravastatin sodium
Dosage FormTablet
Licence HolderApotex Europe B.V.
Licence NumberPA1513/008/003

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA03 pravastatin

Status

License statusWithdrawn
Withdrawn Date23/01/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0014-004-014
Interchangeable List DocumentPDF of Interchangeable List
« Back